The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBF alpha 2 transcription factor

Citation
S. Mcneil et al., The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBF alpha 2 transcription factor, P NAS US, 96(26), 1999, pp. 14882-14887
Citations number
55
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
ISSN journal
00278424 → ACNP
Volume
96
Issue
26
Year of publication
1999
Pages
14882 - 14887
Database
ISI
SICI code
0027-8424(199912)96:26<14882:TTCTIA>2.0.ZU;2-N
Abstract
Targeting of gene regulatory factors to specific intranuclear sites may be critical for the accurate control of gene expression. The acute myelogenous leukemia 8;21 (AML1/ETO) fusion protein is encoded by a rearranged gene cr eated by the ETO chromosomal translocation. This protein lacks the nuclear matrix-targeting signal that directs the AML1 protein to appropriate gene r egulatory sites within the nucleus. Here we report that substitution of the chromosome 8-derived ETO protein for the multifunctional C terminus of AML 1 precludes targeting of the factor to AML1 subnuclear domains. Instead, th e AML1/ETO fusion protein is redirected by the ETO component to alternate n uclear matrix-associated foci. Our results link the ETO chromosomal translo cation in AML with modifications in the intranuclear trafficking of the key hematopoietic regulatory factor, AML1. We conclude that misrouting of gene regulatory factors as a consequence of chromosomal translocations is an im portant characteristic of acute leukemias.